A blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination with one or more businesses. Investors monitor CM Life Sciences due to its focus on identifying targets in the life sciences sector, particularly those with innovative technologies or therapies.
1 member of Congress has disclosed 5 trades in CM Life Sciences, Inc. (CMLFU), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-03-08 | Tom Malinowski | buy | $1K – $15K |
| 2021-03-05 | Tom Malinowski | buy | $1K – $15K |
| 2021-02-25 | Tom Malinowski | buy | $15K – $50K |
| 2020-10-16 | Tom Malinowski | buy | $1K – $15K |
| 2020-10-15 | Tom Malinowski | buy | $1K – $15K |